Result of AGM

RNS Number : 0531P

Venture Life Group PLC

23 May 2018

 

23 May 2018

Venture Life Group plc

("Venture Life" or "the Company")

Result of AGM

Venture Life (AIM: VLG), the international consumer self-care company focused on developing, manufacturing and commercialising products for the self-care market, announces that at its Annual General Meeting held earlier today, all resolutions were duly passed.

Enquiries

Venture Life Group PLC		[phone]
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer
Northland Capital Partners Limited (Nominated Adviser and Joint Broker)		[phone]
Matthew Johnson / Edward Hutton (Corporate Finance)
John Howes / Vadim Alexandre (Corporate Broking)
Turner Pope Investments (TPI) Ltd (Joint Broker)		[phone]
James Pope / Ben Turner
Walbrook PR	[e-mail] or + 44 (0) 20 7933 8780
Anna Dunphy /Paul McManus	[phone] / [phone]

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population.  The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners. 

Through its Development and Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. 

 

END

 

 

RAGUOUARWWAVUAR